Stonerise Capital Management’s Zimmer Biomet ZBH Stock Holding History

Stonerise Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-92,700	Closed	-$10.9M	–	12
2017 Q4	$10.9M	Sell	92,700 -10,300	-10%	-$1.16M	14.81%	3
2017 Q3	$11.7M	Buy	103,000 +77,250	+300%	+$8.92M	18.39%	2
2017 Q2	$3.21M	Hold	25,750	–	–	5.91%	7
2017 Q1	$3.05M	Sell	25,750 -77,250	-75%	-$8.76M	7.04%	6
2016 Q4	$10.3M	Hold	103,000	–	–	11.76%	4
2016 Q3	$13M	Hold	103,000	–	–	9.52%	4
2016 Q2	$12M	Hold	103,000	–	–	6.88%	6
2016 Q1	$10.7M	Buy	+103,000	New	+$9.96M	6.69%	7

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stonerise Capital Management's ZBH Position: Q1 2018 in Review

Stonerise Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 92,700 shares — an estimated $10.9M sold.

Stonerise Capital Management first reported a position in ZBH in Q1 2016 and held it in 8 quarters. The position peaked at $13M in Q3 2016. 875 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

Stonerise Capital Management reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
Stonerise Capital Management sold 92,700 Zimmer Biomet shares in Q1 2018, an estimated $10.9M.
Stonerise Capital Management first reported a position in Zimmer Biomet in Q1 2016 and held it in 8 quarters.
Stonerise Capital Management's Zimmer Biomet position peaked at $13M in Q3 2016.
875 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Stonerise Capital Management's 13F filing for Q1 2018, filed 15 May 2018.